Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy.
Keshari S, Shavkunov AS, Miao Q, Saha A, Minowa T, Molgora M, Williams CD, Chaib M, Highsmith AM, Pineda JE, Alekseev S, Alspach E, Hu KH, Colonna M, Pauken KE, Chen K, Gubin MM. Keshari S, et al. Among authors: hu kh. Cell Rep. 2024 Nov 26;43(11):114875. doi: 10.1016/j.celrep.2024.114875. Epub 2024 Oct 23. Cell Rep. 2024. PMID: 39446585 Free article.
Immediate myeloid depot for SARS-CoV-2 in the human lung.
Magnen M, You R, Rao AA, Davis RT, Rodriguez L, Bernard O, Simoneau CR, Hysenaj L, Hu KH, Maishan M, Conrad C, Gbenedio OM, Samad B, Consortium TUC, Love C, Woodruff PG, Erle DJ, Hendrickson CM, Calfee CS, Matthay MA, Roose JP, Sil A, Ott M, Langelier CR, Krummel MF, Looney MR. Magnen M, et al. Among authors: hu kh. Sci Adv. 2024 Aug 2;10(31):eadm8836. doi: 10.1126/sciadv.adm8836. Epub 2024 Jul 31. Sci Adv. 2024. PMID: 39083602 Free PMC article.
Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy.
Keshari S, Shavkunov AS, Miao Q, Saha A, Williams CD, Highsmith AM, Pineda JE, Alspach E, Hu KH, Pauken KE, Chen K, Gubin MM. Keshari S, et al. Among authors: hu kh. bioRxiv [Preprint]. 2024 Jan 26:2023.12.20.570816. doi: 10.1101/2023.12.20.570816. bioRxiv. 2024. Update in: Cell Rep. 2024 Nov 26;43(11):114875. doi: 10.1016/j.celrep.2024.114875 PMID: 38187708 Free PMC article. Updated. Preprint.
Hill-Chao numbers allow decomposing gamma multifunctionality into alpha and beta components.
Chao A, Chiu CH, Hu KH, van der Plas F, Cadotte MW, Mitesser O, Thorn S, Mori AS, Scherer-Lorenzen M, Eisenhauer N, Bässler C, Delory BM, Feldhaar H, Fichtner A, Hothorn T, Peters MK, Pierick K, von Oheimb G, Müller J. Chao A, et al. Among authors: hu kh. Ecol Lett. 2024 Jan;27(1):e14336. doi: 10.1111/ele.14336. Epub 2023 Dec 10. Ecol Lett. 2024. PMID: 38073071
Multimodal identification of rare potent effector CD8 T cells in solid tumors.
Ray A, Bassette M, Hu KH, Pass LF, Samad B, Combes A, Johri V, Davidson B, Hernandez G, Zaleta-Linares I, Krummel MF. Ray A, et al. Among authors: hu kh. bioRxiv [Preprint]. 2023 Sep 28:2023.09.26.559470. doi: 10.1101/2023.09.26.559470. bioRxiv. 2023. PMID: 37808790 Free PMC article. Preprint.
Metabolic programs of T cell tissue residency empower tumour immunity.
Reina-Campos M, Heeg M, Kennewick K, Mathews IT, Galletti G, Luna V, Nguyen Q, Huang H, Milner JJ, Hu KH, Vichaidit A, Santillano N, Boland BS, Chang JT, Jain M, Sharma S, Krummel MF, Chi H, Bensinger SJ, Goldrath AW. Reina-Campos M, et al. Among authors: hu kh. Nature. 2023 Sep;621(7977):179-187. doi: 10.1038/s41586-023-06483-w. Epub 2023 Aug 30. Nature. 2023. PMID: 37648857 Free PMC article.
99 results